Manifestations of infectious diseases in the oral cavity
Authors:
V. Radochová 1; P. Paterová 2; R. Slezák 1
Authors place of work:
Lékařská fakulta Univerzity Karlovy a Fakultní nemocnice, Hradec Králové
; Stomatologická klinika, Přednosta: doc. MUDr. Radovan Slezák, CSc.
1; Ústav klinické mikrobiologie, Přednosta: prof. MUDr. Pavel Boštík, Ph. D.
2
Published in the journal:
Prakt. Lék. 2020; 100(4): 169-176
Category:
Various Specialization
Summary
Infectious diseases of oral cavity represent wide variety of disorders with possible manifestation in oral region. Viral infections are presented especially as erosive or erythematous lesions, fungal infections as white patches and bacterial infections as ulcers or swelling. Affections usually develop very fast and are accompanied by concurrent symptoms like tenderness, pain, swallowing difficulties and many others. Systemic symptoms are also very frequent and are represented especially by but not limited to malaise, weakness, regional lymph nodes enlargement, fever of other skin efflorescences. Oral manifestations of infections are relatively common and typical. Proper diagnosis can be usually established by complete history a physical oral examination only. Oral infectious symptoms may also reveal unrecognized underlying condition.
Keywords:
oral mucous membrane – viral infection – bacterial infection – mycotic infection
Zdroje
1. Allareddy V, Elangovan S. Characteristics of hospitalizations attributed to herpetic gingivostomatitis: analysis of nationwide inpatient sample. Oral Surg Oral Med Oral Pathol Oral Radiol 2014; 117(4): 471–476.
2. Bandara HMHN, Samaranayake LP. Viral, bacterial, and fungal infections of the oral mucosa: types, incidence, predisposing factors, diagnostic algorithms, and management. Periodontol 2000 2019; 80(1): 148–176.
3. Beachler DC, Sugar EA, Margolick JB, et al. Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. Am J Epidemiol 2015; 181(1): 40–53.
4. Centers for Disease Control and Prevention (CDC). Revised surveillance case definition for HIV infection – United States. MMWR Recomm. Rep 2014; 63(RR-03): 1–10.
5. Chen S-P, Huang Y-C, Li W-C, et al. Comparison of clinical features between coxsackievirus A2 and enterovirus 71 during the enterovirus outbreak in Taiwan, 2008: a children’s hospital experience. J Microbiol Immunol Infect 2010; 43(2): 99–104.
6. Cho S-Y, Lee D-G, Kim H-J. Cytomegalovirus infections after hematopoietic stem cell transplantation: current status and future immunotherapy. Int J Mol Sci 2019; 20(11): 2666.
7. Davison AJ, Eberle R, Ehlers B, et al. The order Herpesvirales. Arch Virol 2009; 154(1): 171–177.
8. Enwonwu CO, Falkler WA, Phillips RS. Noma (cancrum oris). Lancet 2006; 368(9530): 147–156.
9. Fatahzadeh M, Schwartz RA. Oral Kaposi’s sarcoma: a review and update. Int J Dermatol 2013; 52(6): 666–672.
10. Ficarra G, Carlos R. Syphilis: the renaissance of an old disease with oral implications. Head Neck Pathol 2009; 3(3): 195–206.
11. Knipe DM, Howley P. (eds.). Fields Virology. Philadelphia: Lippincott Williams & Wilkins 2019.
12. Folayan MO. The epidemiology, etiology, and pathophysiology of acute necrotizing ulcerative gingivitis associated with malnutrition. J Contemp Dent Pract 2004; 5(3): 28–41.
13. Gbabe OF, Okwundu CI, Dedicoat M, Freeman EE. Treatment of severe or progressive Kaposi’s sarcoma in HIV-infected adults. Cochrane Database Syst Rev 2014; CD003256.
14. Griffiths P, Baraniak I, Reeves M. The pathogenesis of human cytomegalovirus. J Pathol 2015; 235(2): 288–297.
15. Hairston BR, Bruce AJ, Rogers RS. Viral diseases of the oral mucosa. Dermatol Clin 2003; 21(1): 17–32.
16. Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Physician 2014; 90(4): 229–235.
17. International Committee on Taxonomy of Viruses (ICTV). Virus Taxonomy: 2019 Release [online]. Dostupný z https: //talk.ictvonline.org/taxonomy/ [cit. 2020-07-07].
18. Jeon Y, Lee H. Ramsay Hunt syndrome. J Dent Anesth Pain Med 2018; 18(6): 333–337.
19. Jiang M, Abend JR, Johnson SF, Imperiale MJ. The role of polyomaviruses in human disease. Virology 2009; 384(2): 266–273.
20. Johnson RW, Rice ASC. Clinical practice. Postherpetic neuralgia. N Engl J Med 2014; 371(16): 1526–1533.
21. Kolokotronis A, Doumas S. Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis. Clin Microbiol Infect 2006; 12(3): 202–211.
22. Koning S, van der Sande R, Verhagen AP, et al. Interventions for impetigo. Cochrane Database Syst Rev 2012; CD003261.
23. Leuci S, Martina S, Adamo D, et al. Oral syphilis: a retrospective analysis of 12 cases and a review of the literature. Oral Dis 2013; 19(8): 738–746.
24. Lizzi J, Hill T, Jakubowski J. Varicella zoster virus encephalitis. Clin Pract Cases Emerg Med 2019; 3(4): 380–382.
25. López-Sánchez A, Guijarro-Guijarro B, Hernández-Vallejo G. Human repercussions of foot and mouth disease and other similar viral diseases. Med Oral 2003; 8(1): 26–32.
26. Maffini E, Giaccone L, Festuccia M, et al. Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation. Expert Rev Hematol 2016; 9(6): 585–596.
27. Morshed MG, Singh AE. Recent trends in the serologic diagnosis of syphilis. Clin Vaccine Immunol 2015; 22(2): 137–147.
28. Mosmann JP, Talavera AD, Criscuolo MI, et al. Sexually transmitted infections in oral cavity lesions: Human papillomavirus, Chlamydia trachomatis, and Herpes simplex virus. J Oral Microbiol 2019; 11(1): 1632129.
29. Murakami S, Mealey BL, Mariotti A, Chapple ILC. Dental plaque-induced gingival conditions. J Clin Periodontol 2018; 45(Suppl 20): S17–27.
30. Mustafa MB, Arduino PG, Porter SR. Varicella zoster virus: review of its management. J Oral Pathol Med 2009; 38(9): 673–688.
31. Nassef C, Ziemer C, Morrell DS. Hand-foot-and-mouth disease: a new look at a classic viral rash. Curr Opin Pediatr 2015; 27(4): 486–491.
32. Pantanowitz L, Khammissa RAG, Lemmer J, Feller L. Oral HIV-associated Kaposi sarcoma. J Oral Pathol Med 2013; 42(3): 201–207.
33. Patil S, Rao RS, Majumdar B, Anil S. Clinical appearance of oral candida infection and therapeutic strategies. Front Microbiol 2015; 6: 1391.
34. Rahimi H, Mara T, Costella J, et al. Effectiveness of antiviral agents for the prevention of recurrent herpes labialis: a systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 113(5): 618–627.
35. Rubright JH, Shafritz AB. The herpetic whitlow. J Hand Surg 2011; 36(2): 340–342.
36. Ryder MI, Nittayananta W, Coogan M, et al. Periodontal disease in HIV/AIDS. Periodontol 2000. 2012; 60(1): 78–97.
37. Saguil A, Kane SF, Lauters R, Mercado MG. Hand-foot-and-mouth disease: rapid evidence review. Am Fam Physician 2019; 100(7): 408–414.
38. Said AK, Leao JC, Fedele S, Porter SR. Focal epithelial hyperplasia – an update. J Oral Pathol Med 2013; 42(6): 435–442.
39. Sällberg M. Oral viral infections of children. Periodontol 2000 2009; 49: 87–95.
40. Samaranayake LP, Leung WK, Jin L. Oral mucosal fungal infections. Periodontol 2000 2009; 49(1): 39–59.
41. Singh A, Verma R, Murari A, Agrawal A. Oral candidiasis: an overview. J Oral Maxillofac Pathol 2014; 18(Suppl 1): S81–85.
42. Slezák R. Infekční choroby ústní sliznice. Praha: Grada Publishing 1997.
43. Slots J. Oral viral infections of adults. Periodontol 2000 2009; 49(1): 60–86.
44. Stoopler ET, Greenberg MS. Update on herpesvirus infections. Dent Clin North Am 2003; 47(3): 517–532.
45. Tovaru S, Parlatescu I, Tovaru M, et al. Recurrent intraoral HSV-1 infection: A retrospective study of 58 immunocompetent patients from Eastern Europe. Med Oral Patol Oral Cir Bucal 2011; 16(2): e163–169.
46. Tubridy E, Kelsberg G, St Anna L. Clinical inquiry: which drugs are most effective for recurrent herpes labialis? J Fam Pract 2014; 63(2): 104–105.
47. Vale DA do, Martins FME, Silva PHB da, Ortega KL. Retrospective analysis of the clinical behavior of oral hairy leukoplakia in 215 HIV-seropositive patients. Braz Oral Res 2016; 30(1): e118.
48. Yousefi L, Leylabadlo HE, Pourlak T, et al. Oral spirochetes: Pathogenic mechanisms in periodontal disease. Microb Pathog 2020; 144: 104193.
Štítky
General practitioner for children and adolescents General practitioner for adultsČlánok vyšiel v časopise
General Practitioner
2020 Číslo 4
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Memantine Eases Daily Life for Patients and Caregivers
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
Najčítanejšie v tomto čísle
- Manifestations of infectious diseases in the oral cavity
- ERAS concept and its contribution to intensive care
- Laryngocele – current view of the issue
- Two current pandemics: obesity and COVID-19